Skip to main content
VCbacked
Log inGet Started

IMMvention Therapeutix

Chapel Hill, United States

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.

$2.0M raised
Jan 2023
Venture - Series Unknown
BiotechnologyHealth CareTherapeutics

Top Investors

North Carolina Biotechnology Center

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about IMMvention Therapeutix

How much funding has IMMvention Therapeutix raised?
IMMvention Therapeutix has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.
Who are IMMvention Therapeutix's investors?
IMMvention Therapeutix's investors include North Carolina Biotechnology Center.
Where is IMMvention Therapeutix headquartered?
IMMvention Therapeutix is headquartered in Chapel Hill, United States.
What does IMMvention Therapeutix do?
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.
What stage is IMMvention Therapeutix at?
IMMvention Therapeutix is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"IMMvention Therapeutix — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/immvention-therapeutix. Accessed July 2, 2026.
APA
VCBacked. (2023). IMMvention Therapeutix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/immvention-therapeutix
Wikipedia (cite web)
{{cite web |title=IMMvention Therapeutix — Funding & Investors |url=https://www.vcbacked.co/company/immvention-therapeutix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K